Please try another search
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| BIONc1:NS | NSE | INR | Delayed | |
| BION | NSE | INR | Real-time | |
| BIONc2:NS | NSE | INR | Delayed | |
| BIONc3:NS | NSE | INR | Delayed | |
| BION | BSE | INR | Delayed |
Wockhardt (NS:WCKH) shares jumped by 14% today as it completed the phase-3 pneumonia study of macrolide antibiotic Nafithromycin. However, if we talk about the valuations, as per...
Although the market is trading flat for the day so far, with the benchmark Nifty 50 index quoting at 19,579, by 11:03 PM IST, one sector that is still shining even after a...
For mean reversion traders, one counter that has come on my radar and should be on your watchlist is Biocon Limited (NS:BION). It is a well-known biotechnology company with a...
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Sell | Buy | Buy |
| Technical Indicators | Strong Buy | Neutral | Strong Sell | Sell | Strong Buy |
| Summary | Strong Buy | Neutral | Strong Sell | Neutral | Strong Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Completed Patterns | |||||
| Engulfing Bearish | 1W | 2 | May 31, 2026 | ||
| Bullish Engulfing | 1D | 8 | Jun 04, 2026 | ||
| Downside Gap Three Methods | 1W | 9 | Apr 12, 2026 | ||
| Bullish Engulfing | 1W | 9 | Apr 12, 2026 | ||
| Engulfing Bearish | 1M | 10 | Aug 25 | ||
| Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| NSE | 417.75 | 417.20 | 417.70 | 4,202,500 | +0.20% | INR | 15:29:32 | ||
| NSE | 416.45 | 416.50 | 416.45 | 2,806,167 | +0.10% | INR | 15:29:59 | ||
| NSE | 419.80 | 419.00 | 419.80 | 557,500 | +0.10% | INR | 15:29:11 | ||
| NSE | 421.25 | 421.10 | 422.25 | 22,500 | -0.06% | INR | 14:23:47 | ||
| BSE | 416.30 | 416.30 | 417.00 | 78,000 | +0.01% | INR | 15:29:59 |
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| HDFC Bank | 784.90 | 787.70 | 779.45 | +7.55 | +0.97% | 27.82M | 15:29:59 | ||
| Reliance Industries | 1,328.80 | 1,333.40 | 1,306.40 | +21.80 | +1.67% | 18.51M | |||
| Larsen & Toubro | 4,186.40 | 4,235.40 | 4,177.10 | +16.60 | +0.40% | 2.65M | |||
| Yes Bank | 23.89 | 24.49 | 23.45 | +0.11 | +0.46% | 219.39M | 15:29:59 | ||
| Vedanta | 299.95 | 304.30 | 295.60 | -2.55 | -0.84% | 21.93M | 15:29:59 | ||
| ICICI Bank | 1,334.30 | 1,337.30 | 1,326.30 | +6.70 | +0.50% | 13.07M | 15:29:59 | ||
| Suzlon Energy | 57.92 | 59.24 | 53.90 | +2.35 | +4.23% | 292.44M | 15:29:59 | ||
| Tata Consultancy | 2,199.00 | 2,209.00 | 2,160.60 | +37.00 | +1.71% | 3.08M | 15:29:59 | ||
| SBI | 1,015.30 | 1,026.55 | 1,007.40 | -5.55 | -0.54% | 9.69M | 15:29:59 | ||
| Infosys | 1,143.60 | 1,153.80 | 1,123.20 | +8.70 | +0.77% | 10.46M | 15:29:59 |
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services, and other research and development in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
